Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: China Pharma(CPHI) the Revenue is 948.34 K (-7.55%);the EBIT is -1.432 M (-185.6%);the EPS is -0.036 (+77.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B7.55%
----
----
EBIT
-0.00B185.55%
----
----
EPS
-0.03677.78%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf